AU6606500A - Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) - Google Patents

Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)

Info

Publication number
AU6606500A
AU6606500A AU66065/00A AU6606500A AU6606500A AU 6606500 A AU6606500 A AU 6606500A AU 66065/00 A AU66065/00 A AU 66065/00A AU 6606500 A AU6606500 A AU 6606500A AU 6606500 A AU6606500 A AU 6606500A
Authority
AU
Australia
Prior art keywords
cox
cyclooxygenase
canine
canine cyclooxygenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66065/00A
Inventor
James K. Gierse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of AU6606500A publication Critical patent/AU6606500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083Miscellaneous (1.14.99)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU66065/00A 1999-08-06 2000-08-04 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) Abandoned AU6606500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14760199P 1999-08-06 1999-08-06
US60147601 1999-08-06
PCT/US2000/019565 WO2001011026A1 (en) 1999-08-06 2000-08-04 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)

Publications (1)

Publication Number Publication Date
AU6606500A true AU6606500A (en) 2001-03-05

Family

ID=22522196

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66065/00A Abandoned AU6606500A (en) 1999-08-06 2000-08-04 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)

Country Status (6)

Country Link
AR (1) AR025049A1 (en)
AU (1) AU6606500A (en)
CO (1) CO5280149A1 (en)
PE (1) PE20010691A1 (en)
UY (1) UY26279A1 (en)
WO (1) WO2001011026A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001276210A1 (en) 2000-07-18 2002-01-30 National Research Council Of Canada Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
US7179627B2 (en) 2001-09-28 2007-02-20 Brigham Young University Cyclooxygenase variants and methods of use
EP2944957B1 (en) 2003-12-17 2018-08-22 Fred Hutchinson Cancer Research Center Methods and materials for canine breed identification
AU2009208035B2 (en) * 2008-01-22 2014-04-03 Dogenes Inc. Compositions and methods for detecting Juvenile Renal Dysplasia or calcium oxalate stones in dogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69324820T2 (en) * 1992-09-22 2000-01-13 The University Of Rochester, Rochester STABLY TRANSFORMED MAMMAL CELLS THAT EXPRESS A CONTROLLED, INFLAMMABLE CYCLOOXYGENASE
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
WO1996040720A1 (en) * 1995-06-07 1996-12-19 University Of Rochester Mammalian prostaglandin h synthase-2

Also Published As

Publication number Publication date
PE20010691A1 (en) 2001-06-27
CO5280149A1 (en) 2003-05-30
WO2001011026A1 (en) 2001-02-15
WO2001011026A9 (en) 2002-07-25
UY26279A1 (en) 2000-12-29
AR025049A1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
AU2002233998A1 (en) Tahitian noni juice on cox-1 and cox-2 and tahitian noni juice as a selective cox-2 inhibitor
AU2003241478A1 (en) Nanoparticulate sterol formulations and sterol combinations
AU2001275936A1 (en) Controlling and managing digital assets
AU2001267475A1 (en) Combinations of Enzyme Inhibitor-Containing Preparations and the use thereof
AU3334501A (en) Construction element and joining member
AU2002235252A1 (en) Deblurring and re-blurring image segments
AU2002237274A1 (en) Assay method, tnf modulator and its use
AU2002225470A1 (en) Hybrid-mesh cast sleeve and method
AU2003226558A1 (en) Trunking and coupling means therefor
AU2003253079A1 (en) Hydraulic device for the thermo-pneumatic insulation and optional agitation of the contents of an operative cavity
AU6606500A (en) Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2)
AU2002327623A1 (en) Cox-2 function and wound healing
AU2003226556A1 (en) Trunking and coupling means therefor
AU2002364612A1 (en) METHODS AND MATERIALS FOR MODULATING ENaC-BETA
AU7957000A (en) Cyclooxygenase-2 expression inhibitors
AUPR857301A0 (en) Printing elements and methods of construction
AU2002367431A1 (en) Drugs against obeisty and drugs against fatty liver
AU2003259318A1 (en) Powder mixing microchip, system and method
AU2002355975A1 (en) Plasmids from anaerocellum thermophilum and uses thereof
AU3953899A (en) Cyclooxygenase-2 inhibitors
AU2003291136A1 (en) Redd1, a transcriptional target of p63 and p53, and methods of use therefor
AU3421301A (en) Method of providing services of handling civil affair report and guarantee on internet
AU2001281985A1 (en) Substituted aryl ketones and their use as herbicides
AU2003282044A1 (en) Coloring of digital text elements and/or image elements
AU3976900A (en) Combination of p53 gene and e1b-deleted p53 gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase